Table 1.
Statistical characteristics of the full data-set.
| Features | Total subjects | p-value |
|---|---|---|
| AVR type (TAVI) | 54 (33%) | 0.262 |
| Sex (male) | 80 (48%) | 0.147 |
| Smoking | 45 (27%) | 0.200 |
| Hypertension | 136 (73%) | 0.154 |
| ASCVD | 33 (20%) | 0.958 |
| Atrial fibrillation | 42 (25%) | 0.96 |
| CHIP | 49 (30%) | 0.025 |
| Age | 79.15 ± 5.19 | 0.054 |
| BMI | 26.989 ± 3.853 | 0.093 |
| Hemoglobin | 12.832 (11.800–13.800) | 0.048 |
| Glucose | 111.62 (92.000–119.000) | 0.260 |
| eGFR | 61.58 (46.000–74.000) | 0.302 |
| Albumin | 4.03 (3.800–4.300) | 0.002 |
| LDL | 89.69 (71.800–103.200) | 0.202 |
| LV-EF (%) | 59.20 (54.233–66.670) | 0.189 |
| Mean aortic gradient | 45.93 (39.750–51.000) | 0.938 |
| Death (event) | 22 (13%) | – |
| Time (days) | 88 (373–448) | – |
Results are reported as mean ± standard deviation for normally distributed variables and median and inter-quartile range for non-normally distributed. The entity count and percentage are reported for categorical variables, and statistically significant values (p-value < 0.05) are in bold.